3D Hip Study - Parameters derived from DXA-based structural engineering models of the proximal femur as a biomarker for hip fracture prediction.
arcOGEN - The University of Sheffield is one of 11 centres participating in this nationwide study to identify the genetic determinants of osteoarthritis. For more information, see the study website at http://www.arcogen.org.uk/.
Carcinoid and Bone Study - Effects of serotonin excess on bone in carcinoid syndrome.
FAB (Fat and Bone) - The effects of obesity on bone structure and strength: a cross-sectional, observational study of healthy volunteers in South Yorkshire, UK.
- Sub-study: interactions between fracture risk and cardiovascular risk in obesity.
Forsteo - Teriparatide (Forsteo) treatment in postmenopausal women: mechanism of action.
High bone mass study - Molecular genetics of high bone mineral density.
ICUROS - The International Costs and Utilities Related to Osteoporotic Fractures Study: A multinational data collection study.
Metal ions - Systemic effects of chronic metal ion exposure from metal-on metal hip resurfacing.
Prism – Multi-centre, randomised controlled trial of symptomatic vs. intensive bisphosphonate therapy for Paget’s disease.
Scoop – Mulit-centre, randomised controlled trial to evaluate the effectiveness of screening for subjects at ahigh risk of osteoporotic fracture.
Strain gauge - Measurement of induced strains in the human tibia during vibration therapy and habitual activities.
Trio – Bisphosphonate action on the appendicular skeleton: evidence for differential effects. A 2-year randomised parallel group trial of alendronate, ibandronate and risedronate for postmenopausal osteoporosis in secondary care.
XtremeCT – Evaluation of the XTremeCT device for the assessment of bone.
For more information on any of our projects, please contact the Research Programme Managers
Angela Rogers 0114 2266472 (angela.rogers@sheffield.ac.uk)
Lynne Ferrar 0114 271 5881 (L.Ferrar@sheffield.ac.uk)
